Safety Leadership to prevent Serious Injuries and Fatalities (SIF) with Krause Bell Group & GSK, 2/4, 2025
- Apr 2, 2025
- 3 min read
What?
As a follow up to the webinar in February 2025, Filip Coumans from Krause Bell Group, together with Craig Henderson, global EHS Director of the pharmaceutical giant GSK (GlaxoSmithKline), presented what they have done to reduce and prevent Serious Injuries and Fatalities (SIF) in practice. An important component was the roll-out of a Safety Leadership Experience for all their leaders globally, touching on 3 key components:
Safety Leadership Core: what do leaders need to know and apply in their day to day activities to have a meaningful impact on SIF exposure.
Meaningful Safety Conversations: how to have a constructive conversation and gather relevant information on SIF Precursors.
Safe Decision Making® module, enhancing decision making relevant to SIF precursors.
Craig and Filip covered various elements:
How they started
The successes and challenges during the roll-out
What are some results of the overall approach
What are next steps?
As always, the audience also got the chance to ask their questions.
The webinar was held in English.
Before looking into the material from this webinar, there is no requirement to have watched the recording of the first webinar with Krause Bell Group
About Krause Bell Group
Krause Bell Group is dedicated to the prevention of Serious Incidents and Fatalities by improving how your organization functions. Our research-based interventions strengthen decision-making and leadership, address behaviour and build culture to create safe, healthy, and high-performing organisations.
Founding partners, Dr. Tom Krause and Kristen Bell, launched Krause Bell Group in 2015 to provide insights to organizations that seek safety improvement. From deepening the understanding of serious injuries and fatalities to developing tools to measure safety leadership capability and cultural attributes, Krause and Bell have provided thought leadership in safety for the past 25 years. The Krause Bell Group guiding ethos is “Data Driven Innovation.” Conducting studies of leading organizations for over 30 years, Krause and Bell have written widely about SIF (Serious Injury and Fatality) prevention, safety leadership and culture, and rethinking employee engagement methods.
About Filip Coumans
Filip Coumans is Managing Director, EMEA at Krause Bell Group. Filip has 20 years of professional experience, with half of that time dedicated to the safety field. He is a sought-after expert who provides valuable insights to senior executives, helping them develop and implement strategic safety improvement initiatives. Filip's expertise lies in guiding leaders at all levels to achieve real and lasting safety improvements by fostering stronger safety leadership. Filip resides in Antwerpen, Belgium.
About GSK
GSK (acronym of GlaxoSmithKline) is one of the world's largest pharmaceutical company with over 70 000 employees in over 75 countries. The main four core therapeutic areas include infectious diseases, HIV, respiratory/immunology and oncology. The headquarter is located in London. The company is listed on the London Stock Exchange.
About Craig Henderson
Craig Henderson is the Global EHS Director at GSK. Craig has 35 years of experience in the pharmaceutical industry. An Industrial Chemist that has spent most of his professional career working in high hazard facilities and has accumulated over 15 years of experience in Environment, Health and Safety. Craig’s current focus is on improving Safety Leadership and the overall management of SIF activities across GSK.
Material
Presentation
The presentation from the webinar can be downloaded HERE.
Contact information
If you want to get in touch with Filip and Craig, you can connect with them on LinkedIn and/or through their emails:
Filip Coumans, Managing Director EMEA, Krause Bell Group
Craig Henderson, EHS Director, GSK (GlaxoSmithKline)
Recording
A recording of the webinar can be seen on SÄKUPlay (Youtube) below.